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We carried out a nationwide case–control study of childhood brain tumours in Sweden (n¼512) by histological subtype in relation
to prenatal ultrasound, extracting data from antenatal records and the Medical Birth Register. We found no increased risk for brain
tumour after ultrasound exposure, either for all tumours or for any subgroup.
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Since prenatal ultrasound scanning was introduced more than 40
years ago (Donald et al, 1958), ultrasound machines have
multiplied their acoustic output several fold (Henderson et al,
1995), scans are more frequent and Doppler ultrasound is used.
During this same period, the incidence of childhood brain tumours
(CBT) has increased (Hjalmars et al, 1999; NCI, 2005), although
whether this reflects a true increase or merely an improved
diagnosis or reporting is not known (Smith et al, 1998). Thus, it is
important to determine if environmental factors such as prenatal
ultrasound could have contributed to the observed increase.
Previous studies on prenatal ultrasound exposure and childhood
cancer have failed to show any clear association (Cartwright et al,
1984; Kinnier Wilson and Waterhouse, 1984; Bunin et al, 1994; Shu
et al, 1994; Sorahan et al, 1995; Naumburg et al, 2000); only a few
studies have evaluated CBT separately (Cartwright et al, 1984;
Bunin et al, 1994; Shu et al, 1994) and only one published study
has evaluated prenatal ultrasound according to CBT subtypes
(Bunin et al, 1994). These studies were based on retrospectively
collected data and recall bias cannot be ruled out.
In the present nationwide population-based case–control study,
we used prospectively recorded exposure data to study the
associations between prenatal ultrasound exposure and CBT
subtypes.
MATERIALS AND METHODS
In the nationwide Swedish Cancer Register, we identified as cases
601 children born between 1975 and 1984 and with a diagnosis of
brain tumour (ICD-7 code 193) before the age of 15. The same
number of controls were randomly selected from the Medical Birth
Register and frequency matched to cases by gender and year of
birth. With this sample and assuming a power of 80%, a two-sided
5% significance level and an ultrasound exposure frequency of
50%, we estimated that we should be able to detect an odds ratio
(OR) of at least 1.4 for all CBT. For 62 out of the 601 cases, the
information on personal identification numbers or hospital of
birth was incomplete or missing, which made it impossible to
identify their antenatal records. Out of the remaining 539 cases, we
retrieved antenatal records for 512 (95%), and for the 539 controls,
524 antenatal records (97%).
Information on mother’s reproductive history and obstetric
parameters was retrieved from the Medical Birth Register. From
the antenatal records, we extracted information on ultrasound
exposure, including gestational age at exposure and number of
examinations. All data collections were blind to case/control
status. Individual record linkage was made possible by the
personal identification number assigned to each Swedish resident
at birth.
Associations were evaluated for all types of CBT combined and
by the following subtypes: low-grade astrocytoma, high-grade
astrocytoma, primitive neuroectodermal tumour (PNET), ependy-
moma, germ-cell tumour or other rare and incompletely specified
tumours.
We used logistic regression to evaluate the association between
prenatal exposure to ultrasound and the incidence of CBT.
Estimates of ORs and 95% confidence intervals (CIs) were
calculated. A priori, we identified potential confounding factors
that could interfere with both ultrasound exposure and outcome
(CBT), and for which it was possible to retain information from
either the registers or the antenatal records. The following
confounders were included in the adjusted analyses: maternal
age at birth, parity, multiple births, mother’s country of birth
(Nordic (Sweden, Norway, Denmark, Finland and Iceland) or non-
Nordic country), mother’s smoking habits, hypertension, mode of
delivery, breech position, gestational age at birth, birth weight,
head circumference at birth and the level of hospital where born.
Statistical analyses were conducted with the SAS 9.1 software
Received 5 December 2007; revised 28 January 2008; accepted 30
January 2008; published online 18 March 2008
*Correspondence: Dr K Sta ˚lberg; E-mail: karin.stalberg@kbh.uu.se
British Journal of Cancer (2008) 98, 1285–1287
& 2008 Cancer Research UK All rights reserved 0007– 0920/08 $30.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
ypackage. A detailed description of population and study methods
has been published elsewhere (Stalberg et al, 2007).
This study was approved by the Ethics Committees at
Karolinska Institutet and Uppsala University.
RESULTS
In children with CBT, 50.4% were boys and 49.6% girls. Among
children with CBT, it was more common to be the first-born child
(P¼0.01), and to be born at a primary- or secondary-level hospital
(P¼0.04), than for controls. No other significant differences
between cases and controls were seen in maternal and neonatal
characteristics (Stalberg et al, 2007). The median age for diagnosis
for all CBT was 8 years. For the subtypes, the median ages were as
follows: ependymoma, 4 years; PNET, 6 years; low- and high-grade
astrocytoma, 8 and 9 years, respectively; and germ-cell tumours,
9 years.
The overall exposure rate for ultrasound was 44.1% (n¼226) for
case mothers and 45.7% (n¼240) for control mothers. All
ultrasound examinations were performed abdominally and none
involved Doppler ultrasound. In Table 1, the distributions of the
CBT subtypes and ORs according to prenatal ultrasound exposure
are presented. Being exposed to prenatal ultrasound was not
associated with an increased overall risk of brain tumours
compared with being unexposed (adjusted OR 1.00, 95% CI:
0.77–1.29). When stratifying according to histological subgroups,
no increased risks were observed for low- and high-grade
astrocytomas or for PNET. For ependymomas and germ-cell
tumours, cases were too few (44 and 17, respectively) to perform
multivariate analyses with adjustments for possible confounders.
However, there were no increased risks seen in the crude risk
estimates (presented in Table 1).
In Table 2, crude and adjusted ORs for all CBT by trimester of
ultrasound exposure are shown, including exposure exclusively in
one trimester and for combinations with other trimesters. No
specific trimester of ultrasound exposure or any combination of
trimesters was associated with a significantly increased risk of
CBT. The highest OR was observed for exposure in the second
trimester, together with at least one exposure in another trimester
(adjusted OR 1.27, 95% CI: 0.85–1.90). Being exposed to two or
more ultrasound examinations was not associated with any
significantly increased risk of CBT, compared with being
unexposed (crude OR 0.97, 95% CI: 0.71–01.32; adjusted OR
1.09, 95% CI: 0.78–1.52).
DISCUSSION
This is the first study on prenatal ultrasound exposure and
subsequent risk of CBT subtypes using prospectively recorded
exposure information. In agreement with previous studies, we
found no overall increased risk for any separate subtype. The
trimester of exposure and number of ultrasound examinations had
no impact on risks. The finding of no increased risk for PNET,
which is the only subtype of CBT arising from neurones, is in
contrast to the moderately increased risks of PNET by prenatal X-
ray exposure recently reported from the same cohort (Stalberg
et al, 2007).
In most case–control studies of prenatal ultrasound exposure
and CBT risk, the number of cases was small, ranging from 77 to
107 (Cartwright et al, 1984; Shu et al, 1994). Consequently, none of
these studies had sufficient statistical power to study a moderate
association between prenatal ultrasound and CBT. In a study of
321 cases based on retrospective interviews, no increased risks
were seen for astrocytomas and PNET (Bunin et al, 1994). Our
study has the advantage of using exposure data prospectively
recorded during pregnancy, which precludes recall bias. Other
strengths include its population-based design, the blinded data
collection and the few missed cases, which minimize selection bias.
We had the opportunity to control for a number of possible
confounders; these had only minor effects on the results. However,
confounding by indication can be important. In Sweden, most
foetuses are scanned on a routine basis in the second trimester and
further scans are generally performed by indication. The highest
Table 2 Odds ratios and 95% CIs for all childhood brain tumours in relation to trimester of ultrasound exposure
Crude Adjusted
a
Cases Controls OR 95% CI OR 95% CI
Unexposed
b 283 280 1.00 1.00
First trimester (weeks 2–14) Only first 12 17 0.70 0.33–1.49 0.75 0.34–1.63
First and other
c 24 28 0.85 0.48–1.50 0.96 0.53–1.73
Second trimester (weeks 15–28) Only second 64 62 1.02 0.69–1.50 1.05 0.70–1.56
Second and other
c 70 62 1.12 0.76–1.63 1.27 0.85–1.90
Third trimester (weeks 29–45) Only third 53 69 0.76 0.51–1.13 0.82 0.54–1.24
Third and other
c 65 67 0.96 0.66–1.40 1.10 0.74–1.65
Abbreviations: CI¼confidence interval; OR¼odds ratio. Only subjects with information on all variables adjusted for are included. Thirty subjects with uncertain trimester of
ultrasound exposure were excluded.
aAdjusted for maternal age, parity, multiple birth, mother born in a Nordic country, gestational age at birth, mode of delivery, breech
position, birth weight, head circumference at birth, level of hospital, hypertension during pregnancy and maternal smoking.
bReference group.
cIndividuals were also exposed to
ultrasound in at least one of the other trimester. Consequently, one individual can be included in more than one of the ‘other’ row.
Table 1 Odds ratios and 95% CIs for all childhood brain tumours
combined and by subtype in relation to prenatal ultrasound
Crude Adjusted
a
OR 95% CI OR 95% CI
N
b
All brain tumours
c 503 0.94 0.73–1.20 1.00 0.77–1.29
Astrocytoma (low-grade) 190 0.96 0.68–1.34 1.02 0.72–1.44
Astrocytoma (high-grade) 60 0.86 0.50–1.48 1.10 0.62–1.96
PNET 104 0.85 0.55–1.30 0.85 0.54–1.35
Ependymoma
d 42 0.67 0.35–1.29 — —
Germ-cell tumours
d 17 1.07 0.41–2.82 — —
Abbreviations: CI¼confidence interval; OR¼odds ratio; PNET¼primitive neuro-
ectodermal tumour.
aAdjusted for maternal age, parity, multiple birth, mother born in
a Nordic country, gestational age at birth, mode of delivery, breech position, birth
weight, head circumference at birth, level of hospital, hypertension during pregnancy
and maternal smoking.
bNine subjects were excluded because information on
variables adjusted for was missing.
cIncluding the subtypes in the table and other
miscellaneous tumours (n¼90).
dMultivariate analyses could not be performed
because of the low number of cases.
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more trimester (adjusted OR 1.27, 95% CI: 0.85–1.90). Although
not statistically significant, this slightly increased risk may indicate
that children followed-up with further scans had some confounding
factor unknown to us and therefore not adjusted for.
Ultrasound can damage the biological tissue by heating,
cavitation or streaming. Whether any of these mechanisms is
carcinogenic is not known, but experimental studies on tissue
cultures have shown that ultrasound with intensities used for
prenatal scanning can damage cell membranes (Dinno et al, 1989).
In some of the first reports on potential hazards by ultrasound,
chromosomal damages, including sister chromatid exchanges,
were described (Liebeskind et al, 1979) but could not be confirmed
by later studies.
One of the main potential biological effects of prenatal
ultrasound is heating. Bone has the highest absorption coefficient
for heat, and as the CNS tissues are encased in the skull or
vertebrae, the CNS can be subjected to heating by conduction
(Barnett, 1998). The increase in temperature by Doppler ultra-
sound is higher than for B-mode ultrasound only (Barnett, 2001).
The individuals in this study had been exposed to imaging
ultrasound and not to Doppler ultrasound.
No carcinogenic effect of prenatal ultrasound exposure
was found in this or previous studies (Cartwright et al, 1984;
Kinnier Wilson and Waterhouse, 1984; Bunin et al, 1994; Shu et al,
1994; Sorahan et al, 1995; Naumburg et al, 2000). Although
reassuring, these studies assessed ultrasound exposure in the 1970s
and 1980s, when intensity output levels for ultrasound machines
averaged around 20mWcm
 2 spatial peak temporal average
intensity (Duck and Martin, 1991; Kieler et al, 1998). In 1993,
the United States Food and Drug Administration set an overall
limit of 720mWcm
 2 for any type of ultrasound examination
(FDA, 1993). The suspicion of much higher energy exposures
nowadays compared with 20 or 30 years ago in combination with
more frequent scans and the use of Doppler ultrasound means that
possible adverse effects of prenatal ultrasound scanning need to be
monitored in the future.
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